EXPLORE THE SCIENCE
TL;DR: A 35-year-old woman with 20 years of seizures that medicines could not control became seizure-free after surgery removed a small fluid-filled cyst and the nearby part of her brain where seizures started. It is one case, so it cannot prove the cyst cause…
Read article
TL;DR: A 2026 case study in International Medical Case Reports Journal described a 42-year-old man whose chronic insomnia improved after celiac disease was diagnosed and treated with a gluten-free diet, but the report cannot prove gluten exposure caused the sl…
Read article
TL;DR: A 2026 case study in Biomedical Reports described a 28-year-old woman with bipolar II disorder whose stable subclinical counting compulsion worsened and expanded into new obsessive-compulsive symptoms within 3 days of starting cariprazine, then returned…
Read article
TL;DR: A 2026 study in International Clinical Psychopharmacology described a 40-year-old man whose dysphoria, anhedonia, amotivation, and fatigue appeared soon after olanzapine was changed to olanzapine-samidorphan and resolved after he returned to olanzapine…
Read article
TL;DR: A 2026 study in Cureus found that a 55-year-old woman developed anxiety, somatic hypervigilance, and eventual delusional infestation after illicit cosmetic biopolymer injections, raising the possibility that chronic inflammatory exposure can help tip vu…
Read article
TL;DR: A 2026 study in Psychiatry and Clinical Neurosciences Reports described a treatment-resistant residual-phase schizophrenia case in which valproate helped agitation but caused hypoglycemia and pancytopenia, while lithium augmentation was followed by lowe…
Read article
TL;DR: A 2026 paper in Current Therapeutic Research described an acute PGAD-like genital arousal episode after self-initiated duloxetine withdrawal, with symptoms resolving within 5 hours after emergency admission and no recurrence over 36 months. Key Findings…
Read article
TL;DR: A 2026 study in Journal of Medical Case Reports described a 71-year-old breast-cancer survivor whose Montreal Cognitive Assessment (MoCA), a cognitive screening test, increased from 16 to 20 and whose 15-item Geriatric Depression Scale (GDS-15), a depre…
Read article
TL;DR: A 2026 case study in Psychiatry and Clinical Neurosciences Reports described a 36-year-old man with treatment-resistant schizophrenia and focal epilepsy whose psychosis improved after slow clozapine titration, without worsening seizure frequency or seve…
Read article
Guanfacine extended release (GXR) may effectively improve cognitive impairments and brain activity in long-COVID patients. Highlights: Patient Presentation: A 32-year-old woman experienced cognitive impairments such as difficulty in word recall, reading, and w…
Read article